| Breakdown | Mar 2026 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 86.35B | 84.31B | 77.99B | 77.30B | 73.42B |
| Gross Profit | 27.80B | 26.88B | 26.66B | 25.05B | 25.22B |
| EBITDA | 25.47B | 24.81B | 24.19B | 22.91B | 23.32B |
| Net Income | 13.22B | 12.40B | 12.13B | 10.85B | 10.66B |
Balance Sheet | |||||
| Total Assets | 120.46B | 118.27B | 115.57B | 119.65B | 118.61B |
| Cash, Cash Equivalents and Short-Term Investments | 3.42B | 3.51B | 3.16B | 3.26B | 3.19B |
| Total Debt | 16.00M | 10.00M | 43.00M | 106.00M | 198.00M |
| Total Liabilities | 18.54B | 19.07B | 18.09B | 18.52B | 18.42B |
| Stockholders Equity | 98.97B | 96.54B | 95.09B | 98.88B | 96.42B |
Cash Flow | |||||
| Free Cash Flow | 10.53B | 9.53B | 1.82B | 6.78B | 10.64B |
| Operating Cash Flow | 16.33B | 15.09B | 11.33B | 14.64B | 18.77B |
| Investing Cash Flow | -5.38B | -3.57B | 4.91B | -3.94B | -13.82B |
| Financing Cash Flow | -11.04B | -11.17B | -16.35B | -10.63B | -4.85B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥10.79T | 18.28 | ― | 3.99% | 7.55% | 3.27% | |
70 Outperform | ¥328.90B | 24.18 | 13.42% | 2.27% | 2.41% | 9.05% | |
63 Neutral | ¥20.35B | 27.91 | ― | ― | 25.92% | -10.55% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
57 Neutral | ¥13.34T | 12.47 | 11.22% | 3.36% | 5.14% | 5.49% | |
56 Neutral | ¥341.84B | 11.19 | 17.97% | 1.36% | 5.57% | 31.99% | |
56 Neutral | ¥10.52T | 14.83 | 13.75% | 2.85% | 4.05% | 13.53% |